These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 19296694)
1. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity. Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity. Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of salicylic acid and N-acetyl-2-carboxybenzenesulfonamide regioisomers possessing a N-difluoromethyl-1,2-dihydropyrid-2-one pharmacophore: dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity. Chowdhury MA; Abdellatif KR; Dong Y; Das D; Yu G; Velázquez CA; Suresh MR; Knaus EE Bioorg Med Chem Lett; 2009 Dec; 19(24):6855-61. PubMed ID: 19884005 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of N-difluoromethyl-1,2-dihydropyrid-2-one acetic acid regioisomers: dual inhibitors of cyclooxygenases and 5-lipoxygenase. Yu G; Praveen Rao PN; Chowdhury MA; Abdellatif KR; Dong Y; Das D; Velázquez CA; Suresh MR; Knaus EE Bioorg Med Chem Lett; 2010 Apr; 20(7):2168-73. PubMed ID: 20202839 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of 1-(methanesulfonyl- and aminosulfonylphenyl)acetylenes that possess a 2-(N-difluoromethyl-1,2-dihydropyridin-2-one) pharmacophore: evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity. Chowdhury MA; Abdellatif KR; Dong Y; Rahman M; Das D; Suresh MR; Knaus EE Bioorg Med Chem Lett; 2009 Feb; 19(3):584-8. PubMed ID: 19136259 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs). Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of indomethacin analogs possessing a N-difluoromethyl-1,2-dihydropyrid-2-one ring system: a search for novel cyclooxygenase and lipoxygenase inhibitors. Chowdhury MA; Huang Z; Abdellatif KR; Dong Y; Yu G; Velázquez CA; Knaus EE Bioorg Med Chem Lett; 2010 Oct; 20(19):5776-80. PubMed ID: 20727750 [TBL] [Abstract][Full Text] [Related]
8. Phenylacetic acid regioisomers possessing a N-difluoromethyl-1,2-dihydropyrid-2-one pharmacophore: evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity. Yu G; Chowdhury MA; Abdellatif KR; Dong Y; Praveen Rao PN; Das D; Velázquez CA; Suresh MR; Knaus EE Bioorg Med Chem Lett; 2010 Feb; 20(3):896-902. PubMed ID: 20045320 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases. Rao PN; Chen QH; Knaus EE J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of (E)-3-(4-methanesulfonylphenyl)-2-(aryl)acrylic acids as dual inhibitors of cyclooxygenases and lipoxygenases. Moreau A; Chen QH; Praveen Rao PN; Knaus EE Bioorg Med Chem; 2006 Dec; 14(23):7716-27. PubMed ID: 16931030 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 1-(benzenesulfonamido)-2-[5-(N-hydroxypyridin-2(1H)-one)]acetylene regioisomers: a novel class of 5-lipoxygenase inhibitors. Chowdhury MA; Chen H; Abdellatif KR; Dong Y; Petruk KC; Knaus EE Bioorg Med Chem Lett; 2008 Jul; 18(14):4195-8. PubMed ID: 18541424 [TBL] [Abstract][Full Text] [Related]
12. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies. Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors. Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new phenidone analogues as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors. Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T Farmaco; 2005 Jan; 60(1):7-13. PubMed ID: 15652362 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 1,3-diphenylprop-2-yn-1-ones as dual inhibitors of cyclooxygenases and lipoxygenases. Rao PN; Chen QH; Knaus EE Bioorg Med Chem Lett; 2005 Nov; 15(21):4842-5. PubMed ID: 16143531 [TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors. Kolasa T; Brooks CD; Rodriques KE; Summers JB; Dellaria JF; Hulkower KI; Bouska J; Bell RL; Carter GW J Med Chem; 1997 Feb; 40(5):819-24. PubMed ID: 9057869 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases. Moreau A; Rao PN; Knaus EE Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817 [TBL] [Abstract][Full Text] [Related]
19. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase. Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation. Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]